CI
Cambiar Investors Portfolio holdings
AUM
$2.2B
1-Year Est. Return
6.87%
1 Year Est. Return
+6.87%
AUM
$2.38B
AUM Growth
+$18.2M
(+0.77%)
Holding
166
Top Buys
| 1 | +$62.7M | |
| 2 | +$45.8M | |
| 3 | +$32.7M | |
| 4 |
SLB Ltd
SLB
|
+$32M |
| 5 |
AstraZeneca
AZN
|
+$19M |
Top Sells
| 1 | +$47.1M | |
| 2 | +$46.6M | |
| 3 | +$45.1M | |
| 4 |
Goldman Sachs
GS
|
+$31.5M |
| 5 |
CME Group
CME
|
+$27.2M |
Sector Composition
| 1 | Financials | 17.84% |
| 2 | Healthcare | 17.08% |
| 3 | Technology | 13.85% |
| 4 | Consumer Discretionary | 11.51% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
United Parcel Service
UPS
$77.9B
| – | – |
-1,856
|
|
||
152
NOV
NOV
$5.42B
| – | – |
-290,097
|
|
||
153
Maximus
MMS
$4.72B
| – | – |
-103,736
|
|
||
154
Magnolia Oil & Gas
MGY
$4.02B
| – | – |
-489,866
|
|
||
155
Johnson & Johnson
JNJ
$450B
| – | – |
-1,340
|
|
||
156
HealthEquity
HQY
$8.1B
| – | – |
-13,848
|
|
||
157
Gannett
GCI
$756M
| – | – |
-17,103
|
|
||
158
Forrester Research
FORR
$146M
| – | – |
-56,944
|
|
||
159
Expeditors International
EXPD
$18.5B
| – | – |
-83,851
|
|
||
160
Exelixis
EXEL
$10.4B
| – | – |
-43,284
|
|
||
161
Cenovus Energy
CVE
$29.4B
| – | – |
-3,347,074
|
|
||
162
Charles River Laboratories
CRL
$7.95B
| – | – |
-40,665
|
|
||
163
ConocoPhillips
COP
$110B
| – | – |
-448,516
|
|
||
164
AXIS Capital
AXS
$7.41B
| – | – |
-29,756
|
|
||
165
iShares MSCI ACWI ETF
ACWI
$23.2B
| – | – |
-10,347
|
|
||
166
AMN Healthcare
AMN
$745M
| – | – |
-23,330
|
|